These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36627397)

  • 1. Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice.
    Bargiela A; Ten-Esteve A; Martí-Bonmatí L; Sevilla T; Perez Alonso M; Artero R
    Sci Rep; 2023 Jan; 13(1):503. PubMed ID: 36627397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI.
    Heskamp L; van Nimwegen M; Ploegmakers MJ; Bassez G; Deux JF; Cumming SA; Monckton DG; van Engelen BGM; Heerschap A
    Neurology; 2019 Jun; 92(24):e2803-e2814. PubMed ID: 31118244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A low absolute number of expanded transcripts is involved in myotonic dystrophy type 1 manifestation in muscle.
    Gudde AE; González-Barriga A; van den Broek WJ; Wieringa B; Wansink DG
    Hum Mol Genet; 2016 Apr; 25(8):1648-62. PubMed ID: 26908607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophy.
    Furling D; Lam le T; Agbulut O; Butler-Browne GS; Morris GE
    Am J Pathol; 2003 Mar; 162(3):1001-9. PubMed ID: 12598332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of DMPK: correlation with CTG repeat expansion and fibre type composition in myotonic dystrophy type 1.
    Salvatori S; Fanin M; Trevisan CP; Furlan S; Reddy S; Nagy JI; Angelini C
    Neurol Sci; 2005 Oct; 26(4):235-42. PubMed ID: 16193250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative muscle MRI as a sensitive marker of early muscle pathology in myotonic dystrophy type 1.
    van der Plas E; Gutmann L; Thedens D; Shields RK; Langbehn K; Guo Z; Sonka M; Nopoulos P
    Muscle Nerve; 2021 Apr; 63(4):553-562. PubMed ID: 33462896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
    Seznec H; Agbulut O; Sergeant N; Savouret C; Ghestem A; Tabti N; Willer JC; Ourth L; Duros C; Brisson E; Fouquet C; Butler-Browne G; Delacourte A; Junien C; Gourdon G
    Hum Mol Genet; 2001 Nov; 10(23):2717-26. PubMed ID: 11726559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.
    Peric S; Maksimovic R; Banko B; Durdic M; Bjelica B; Bozovic I; Balcik Y; Pesovic J; Savic-Pavicevic D; Rakocevic-Stojanovic V
    J Neurol; 2017 Sep; 264(9):1899-1908. PubMed ID: 28756605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials.
    Garibaldi M; Nicoletti T; Bucci E; Fionda L; Leonardi L; Morino S; Tufano L; Alfieri G; Lauletta A; Merlonghi G; Perna A; Rossi S; Ricci E; Alonso Perez J; Tartaglione T; Petrucci A; Pennisi EM; Salvetti M; Cutter G; Díaz-Manera J; Silvestri G; Antonini G
    Eur J Neurol; 2022 Mar; 29(3):843-854. PubMed ID: 34753219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive skeletal muscle weakness in transgenic mice expressing CTG expansions is associated with the activation of the ubiquitin-proteasome pathway.
    Vignaud A; Ferry A; Huguet A; Baraibar M; Trollet C; Hyzewicz J; Butler-Browne G; Puymirat J; Gourdon G; Furling D
    Neuromuscul Disord; 2010 May; 20(5):319-25. PubMed ID: 20346670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Assessment of Trunk Muscles Involvement in Patients with Myotonic Dystrophy Type 1 Using a Whole Body Muscle Magnetic Resonance Imaging.
    Park D; Park JS
    Eur Neurol; 2017; 77(5-6):238-245. PubMed ID: 28288466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of skeletal muscle wasting in a mouse model for myotonic dystrophy type 1.
    Morriss GR; Rajapakshe K; Huang S; Coarfa C; Cooper TA
    Hum Mol Genet; 2018 Aug; 27(16):2789-2804. PubMed ID: 29771332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endurance exercise leads to beneficial molecular and physiological effects in a mouse model of myotonic dystrophy type 1.
    Sharp L; Cox DC; Cooper TA
    Muscle Nerve; 2019 Dec; 60(6):779-789. PubMed ID: 31509256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI of trunk muscles and motor and respiratory function in patients with myotonic dystrophy type 1.
    Solbakken G; Bjørnarå B; Kirkhus E; Nguyen B; Hansen G; Frich JC; Ørstavik K
    BMC Neurol; 2019 Jun; 19(1):135. PubMed ID: 31216995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower limb muscle magnetic resonance imaging in Chinese patients with myotonic dystrophy type 1.
    Song J; Fu J; Ma M; Pang M; Li G; Gao L; Zhang J
    Neurol Res; 2020 Feb; 42(2):170-177. PubMed ID: 31951783
    [No Abstract]   [Full Text] [Related]  

  • 16. Congenital myotonic dystrophy: variability in muscle involvement and histopathological process.
    Kuo HC; Huang CC; Chu CC; Wai YY; Hsiao KM; Chu NS
    Acta Neurol Taiwan; 2006 Mar; 15(1):13-20. PubMed ID: 16599279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body composition analysis in patients with myotonic dystrophy types 1 and 2.
    Peric S; Bozovic I; Nisic T; Banovic M; Vujnic M; Svabic T; Pesovic J; Brankovic M; Basta I; Jankovic M; Savic-Pavicevic D; Rakocevic-Stojanovic V
    Neurol Sci; 2019 May; 40(5):1035-1040. PubMed ID: 30790082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic exercise mitigates disease mechanisms and improves muscle function in myotonic dystrophy type 1 mice.
    Manta A; Stouth DW; Xhuti D; Chi L; Rebalka IA; Kalmar JM; Hawke TJ; Ljubicic V
    J Physiol; 2019 Mar; 597(5):1361-1381. PubMed ID: 30628727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1.
    Ward AJ; Rimer M; Killian JM; Dowling JJ; Cooper TA
    Hum Mol Genet; 2010 Sep; 19(18):3614-22. PubMed ID: 20603324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
    Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
    Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.